A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder
Clinical trial NCT01914939 · COMPLETED
Trial details
- NCT number
- NCT01914939
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-11-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.